The death of an 83-year-old man who checked into The University of Utah’s hospital after suffering from a routine fall raises concerns that hemorrhaging may be irreversible in patients taking Boehringer Ingelheim’s blood-thinning drug Pradaxa. A new report published Thursday in the Journal of Neurosurgery, authored by physicians in the University’s Neurosurgery Department who treated the patient, details his decline and eventual death hours after arriving at the hospital. The patient went to the hospital after experiencing a standing-level fall that left him banged up but alert and coherent. The study notes that one month prior to his fall, the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.